After hours: December 27 at 4:06:02 PM EST Loading Chart for EXAS ...

Included was a final decision related to CMS pricing for Exact Sciences Corp’s (NASDAQ:EXAS) Cologuard Plus, a second-generation test that received FDA approval in October. William Blair writes ...

For the third quarter of 2024, the Voya Small Cap Growth Strategy underperformed its benchmark. Click here to read the full ...

For Q3 2024, the Voya SmallCap Opportunities Portfolio underperformed its benchmark index. Click here to read the full ...

After hours: 7:35:44 p.m. EST ...

Colon cancer rates are surging worldwide, especially among younger and relatively healthy people, making it more important ...